Liron Kutzi - Photomyne Head HR
| PHTM Stock | ILA 2,786 2.00 0.07% |
Insider
Liron Kutzi is Head HR of Photomyne
| Phone | 972 3 551 8114 |
| Web | https://www.photomyne.com |
Photomyne Management Efficiency
The company has return on total asset (ROA) of (0.1493) % which means that it has lost $0.1493 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (0.4258) %, meaning that it generated substantial loss on money invested by shareholders. Photomyne's management efficiency ratios could be used to measure how well Photomyne manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Showing other executives | INSIDER Age | ||
| Tal FrielMann | IDI Insurance | 51 | |
| Yehuda Reznik | Hiron Trade Investments Industr | 70 | |
| Boaz Leshem | Scope Metals Group | 63 | |
| Andrew Zhang | Israel China Biotechnology | 61 | |
| Stanley ADV | Scope Metals Group | N/A | |
| Alex Master | Scope Metals Group | N/A | |
| Alex Shatzir | Scope Metals Group | N/A | |
| Jacob Haber | IDI Insurance | 55 | |
| Yonatan LeAri | Hiron Trade Investments Industr | 47 | |
| Ester Levy | Hiron Trade Investments Industr | 58 | |
| Guy Goldin | Israel China Biotechnology | 51 | |
| Yossi Efrati | IDI Insurance | 52 | |
| Yehuda Bruner | Israel China Biotechnology | N/A | |
| Zvika CPA | Scope Metals Group | N/A | |
| Eliaz Omer | Scope Metals Group | N/A | |
| Rav Bartov | IDI Insurance | 46 | |
| Shiran Manor | Clal Biotechnology Industries | N/A | |
| Arnon MD | Clal Biotechnology Industries | 54 | |
| Liat Nissan | Clal Biotechnology Industries | N/A | |
| Amir Beker | Israel China Biotechnology | 59 | |
| Yosef Yitzchak | Hiron Trade Investments Industr | 70 | |
Management Performance
| Return On Equity | -0.43 | |||
| Return On Asset | -0.15 |
Photomyne Leadership Team
Elected by the shareholders, the Photomyne's board of directors comprises two types of representatives: Photomyne inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Photomyne. The board's role is to monitor Photomyne's management team and ensure that shareholders' interests are well served. Photomyne's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Photomyne's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Nir Tzemah, Chairman CEO | ||
| Yair Segalovitz, CFO Director | ||
| Natalie Verter, CPO, CoFounder | ||
| Ofir Huber, Head RD | ||
| Mickey Atir, Head Marketing | ||
| Annat Katz, Head Content | ||
| Tal Katz, Head Fin | ||
| Liron Kutzi, Head HR | ||
| Omer Shoor, CTO Director |
Photomyne Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Photomyne a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -0.43 | |||
| Return On Asset | -0.15 | |||
| Profit Margin | (0.31) % | |||
| Operating Margin | (0.28) % | |||
| Shares Outstanding | 2.75 M | |||
| Shares Owned By Institutions | 0.76 % | |||
| Price To Sales | 3.00 X | |||
| Revenue | 15.18 M | |||
| Gross Profit | 8.34 M | |||
| EBITDA | (4.22 M) |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Other Information on Investing in Photomyne Stock
Photomyne financial ratios help investors to determine whether Photomyne Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Photomyne with respect to the benefits of owning Photomyne security.